Canada Immunoprotein Diagnostic Testing Market Size & Outlook

The immunoprotein diagnostic testing market in Canada is expected to reach a projected revenue of US$ 674.6 million by 2030. A compound annual growth rate of 7.4% is expected of Canada immunoprotein diagnostic testing market from 2025 to 2030.
Revenue, 2024 (US$M)
$439.6
Forecast, 2030 (US$M)
$674.6
CAGR, 2025 - 2030
7.4%
Report Coverage
Canada

Canada immunoprotein diagnostic testing market, 2018-2030 (US$M)

Canada immunoprotein diagnostic testing market, 2018-2030 (US$M)
Unlock Premium

Related Markets

Canada immunoprotein diagnostic testing market highlights

  • The Canada immunoprotein diagnostic testing market generated a revenue of USD 439.6 million in 2024 and is expected to reach USD 674.6 million by 2030.
  • The Canada market is expected to grow at a CAGR of 7.4% from 2025 to 2030.
  • In terms of segment, immunoglobulin diagnostic tests was the largest revenue generating test in 2024.
  • Immunoglobulin Diagnostic Tests is the most lucrative test segment registering the fastest growth during the forecast period.

Immunoprotein diagnostic testing market data book summary

Market revenue in 2024USD 439.6 million
Market revenue in 2030USD 674.6 million
Growth rate7.4% (CAGR from 2025 to 2030)
Largest segmentImmunoglobulin diagnostic tests
Fastest growing segmentImmunoglobulin Diagnostic Tests
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationComplement System Proteins Diagnostic Tests, Free Light Chain Diagnostic Tests, Haptoglobin Diagnostic Tests, Immunoglobulin Diagnostic Tests, Prealbumin Diagnostic Tests, C-Reactive Protein (CRP) Diagnostic Tests
Key market players worldwideAgilent Technologies Inc, Danaher Corp, Thermo Fisher Scientific Inc, PerkinElmer, Inc., Bio-Rad Laboratories Inc, Aurora Innovation Inc Class A, Tecan Group AG, Promega, Charles River Laboratories International Inc, Creative-Biolabs

Other key industry trends

  • In terms of revenue, Canada accounted for 4.6% of the global immunoprotein diagnostic testing market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. immunoprotein diagnostic testing market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 5,918.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Immunoprotein Diagnostic Testing Market Companies

Name Profile # Employees HQ Website

Canada Immunoprotein Diagnostic Testing Market Outlook Share, 2024 & 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more